Literature DB >> 29556293

β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.

Boju Pan1, Junchao Guo1, Quan Liao1, Yupei Zhao1.   

Abstract

Integrins are transmembrane glycoproteins that consist of an α and a β subunit. Specific integrin heterodimers preferentially bind to distinct extracellular matrix (ECM) proteins to affect the characteristics of cells or the components of the ECM. Among the different integrins, β1 and β3 integrins serve essential roles in the progression of different cancer-associated processes, including the initiation, proliferation, survival, migration and invasion. Furthermore, previous studies have revealed a ratio between these two integrins in cancer cells, which also demonstrated that the functions of these two integrins are paradoxical. This indicated that the proliferation and metastasis of cancer cells are not always parallel and may be considered independently maintained. Additionally, the present review may assist in understanding certain aspects of cancer, and in making clinical decisions in a novel and more comprehensive manner.

Entities:  

Keywords:  cancer; combination; metastasis; proliferation; β1 integrin; β3 integrin

Year:  2018        PMID: 29556293      PMCID: PMC5844128          DOI: 10.3892/ol.2018.8076

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  51 in total

1.  Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway.

Authors:  D Q Zheng; A S Woodard; M Fornaro; G Tallini; L R Languino
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

2.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Authors:  J C Gutheil; T N Campbell; P R Pierce; J D Watkins; W D Huse; D J Bodkin; D A Cheresh
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

3.  Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma.

Authors:  T Matsuoka; M Yashiro; S Nishimura; T Inoue; T Fujihara; T Sawada; Y Kato; S Seki; K Hirakawa-Ys Chung
Journal:  Int J Mol Med       Date:  2000-01       Impact factor: 4.101

Review 4.  The role of β3-integrins in tumor angiogenesis: context is everything.

Authors:  Stephen D Robinson; Kairbaan M Hodivala-Dilke
Journal:  Curr Opin Cell Biol       Date:  2011-05-10       Impact factor: 8.382

5.  Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer.

Authors:  B Besse; L C Tsao; D T Chao; Y Fang; J-C Soria; S Almokadem; C P Belani
Journal:  Ann Oncol       Date:  2012-08-16       Impact factor: 32.976

6.  Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.

Authors:  Yu-Chen Lee; Jung-Kang Jin; Chien-Jui Cheng; Chih-Fen Huang; Jian H Song; Miao Huang; Wells S Brown; Sui Zhang; Li-Yuan Yu-Lee; Edward T Yeh; Bradley W McIntyre; Christopher J Logothetis; Gary E Gallick; Sue-Hwa Lin
Journal:  Mol Cancer Res       Date:  2013-01-21       Impact factor: 5.852

7.  Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro.

Authors:  Azza Gramoun; Seema Shorey; Jill D Bashutski; S Jeffrey Dixon; Stephen M Sims; Johan N M Heersche; Morris F Manolson
Journal:  J Cell Biochem       Date:  2007-10-01       Impact factor: 4.429

8.  Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Surgery       Date:  2007-05-04       Impact factor: 3.982

9.  Mutant p53 drives invasion by promoting integrin recycling.

Authors:  Patricia A J Muller; Patrick T Caswell; Brendan Doyle; Marcin P Iwanicki; Ee H Tan; Saadia Karim; Natalia Lukashchuk; David A Gillespie; Robert L Ludwig; Pauline Gosselin; Anne Cromer; Joan S Brugge; Owen J Sansom; Jim C Norman; Karen H Vousden
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

10.  Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.

Authors:  Petra Barros dos Santos; Juliana S Zanetti; Alfredo Ribeiro-Silva; Eduardo I C Beltrão
Journal:  Diagn Pathol       Date:  2012-08-16       Impact factor: 2.644

View more
  24 in total

Review 1.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

2.  Cell surface heat shock protein-mediated entry of tumor cell-adapted rotavirus into U-937 cells.

Authors:  José Rico; Claudia Perez; Juan Hernandez; Carlos Guerrero; Orlando Acosta
Journal:  Folia Microbiol (Praha)       Date:  2021-05-05       Impact factor: 2.099

3.  Randomly Distributed K14+ Breast Tumor Cells Polarize to the Leading Edge and Guide Collective Migration in Response to Chemical and Mechanical Environmental Cues.

Authors:  Priscilla Y Hwang; Audrey Brenot; Ashley C King; Gregory D Longmore; Steven C George
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

4.  Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers.

Authors:  Min-Hua Lai; Chi-Hsun Liao; Nu-Man Tsai; Kai-Fu Chang; Cheng-Chi Liu; Yi-Han Chiu; Kuo-Ching Huang; Chen-Si Lin
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 5.  Role of extracellular matrix in breast cancer development: a brief update.

Authors:  Manoj Kumar Jena; Jagadeesh Janjanam
Journal:  F1000Res       Date:  2018-03-05

6.  Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone.

Authors:  Milene N O Moritz; Alyssa R Merkel; Ean G Feldman; Heloisa S Selistre-de-Araujo; Julie A Rhoades Sterling
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

7.  Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010.

Authors:  Julia Samson; Magdalina Derlipanska; Oza Zaheed; Kellie Dean
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

8.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

9.  MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).

Authors:  Wei Zhang; Mingkai Zhang; Lantao Liu; Dan Jin; Pengyu Wang; Jing Hu
Journal:  Med Sci Monit       Date:  2018-10-07

10.  HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression.

Authors:  Jasmina Makarević; Jochen Rutz; Eva Juengel; Sebastian Maxeiner; Jens Mani; Stefan Vallo; Igor Tsaur; Frederik Roos; Felix K-H Chun; Roman A Blaheta
Journal:  Cells       Date:  2018-09-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.